tiprankstipranks
Cencora, Inc. (CH:ABG)
NYSE:ABG
Switzerland Market
ABG
Cencora
RESEARCH TOOLSreports

Cencora (ABG) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

ABG Analyst Ratings

Strong Buy
10Ratings
Strong Buy
8 Buy
2 Hold
0 Sell
Based on 10 analysts giving stock ratings to
Cencora
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ABG Stock 12 Month Forecast

Average Price Target

$280.23
Based on 10 Wall Street analysts offering 12 month price targets for Cencora in the last 3 months. The average price target is $280.23 with a high forecast of $333.68 and a low forecast of $230.82. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$333.68Average Price Target$280.23Lowest Price Target$230.82
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on CH:ABG
Allen Lutz
Bank of America Securities
Bank of America Securities
CHF226.77→CHF230.82
Hold
―
Reiterated
06/24/26
Analysts Offer Insights on Healthcare Companies: Cencora (NYSE: COR), UnitedHealth (NYSE: UNH) and Humana (NYSE: HUM)
Barclays Analyst forecast on CH:ABG
Glen Santangelo
Barclays
Barclays
CHF344.21→CHF283.47
Buy
―
Reiterated
06/10/26
Barclays Reaffirms Their Buy Rating on Cencora (COR)
TD Cowen Analyst forecast on CH:ABG
Charles Rhyee
TD Cowen
TD Cowen
CHF323.96
Buy
―
Assigned
06/01/26
TD Cowen Reaffirms Their Buy Rating on Cencora (COR)
Wells Fargo Analyst forecast on CH:ABG
Stephen Baxter
Wells Fargo
Wells Fargo
CHF268.08
Buy
―
Reiterated
05/28/26
Cencora (COR) Receives a Buy from Wells Fargo
William Blair Analyst forecast on CH:ABG
Max Smock
William Blair
William Blair
―
Hold
―
Reiterated
05/22/26
Analysts Offer Insights on Healthcare Companies: Immuneering (NASDAQ: IMRX) and Cencora (NYSE: COR)
Morgan Stanley Analyst forecast on CH:ABG
Erin Wright
Morgan Stanley
Morgan Stanley
CHF323.96→CHF276.99
Buy
―
Reiterated
05/08/26
Cencora price target lowered to $342 from $400 at Morgan StanleyCencora price target lowered to $342 from $400 at Morgan Stanley
Robert W. Baird Analyst forecast on CH:ABG
Eric Coldwell
Robert W. Baird
Robert W. Baird
CHF340.16→CHF274.56
Buy
―
Reiterated
05/07/26
Cencora price target lowered to $339 from $420 at BairdCencora price target lowered to $339 from $420 at Baird
UBS Analyst forecast on CH:ABG
Kevin Caliendo
UBS
UBS
CHF332.06→CHF333.68
Buy
―
Reiterated
05/07/26
Cencora price target raised to $412 from $410 at UBSCencora price target raised to $412 from $410 at UBS
Citi Analyst forecast on CH:ABG
Daniel Grosslight
Citi
Citi
CHF328.01→CHF287.52
Buy
―
Reiterated
05/07/26
Cencora price target lowered to $355 from $405 at CitiCencora price target lowered to $355 from $405 at Citi
Evercore ISI Analyst forecast on CH:ABG
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
CHF291.57→CHF242.97
Buy
―
Reiterated
05/07/26
Cencora price target lowered to $300 from $360 at Evercore ISICencora price target lowered to $300 from $360 at Evercore ISI
Argus Research Analyst forecast on CH:ABG
David Toung
Argus Research
Argus Research
CHF323.96
Buy
―
Reiterated
03/17/26
Analysts Offer Insights on Healthcare Companies: Nuvation Bio (NYSE: NUVB) and Cencora (NYSE: COR)
J.P. Morgan Analyst forecast on CH:ABG
Lisa Gill
J.P. Morgan
J.P. Morgan
CHF337.73→CHF339.35
Buy
―
Reiterated
02/10/26
Cencora price target raised to $419 from $417 at JPMorganCencora price target raised to $419 from $417 at JPMorgan
Jefferies Analyst forecast on CH:ABG
Brian Tanquilut
Jefferies
Jefferies
CHF267.27→CHF356.36
Buy
―
Upgraded
01/22/26
Cencora upgraded to Buy from Hold at JefferiesCencora upgraded to Buy from Hold at Jefferies
Deutsche Bank Analyst forecast on CH:ABG
George Hill
Deutsche Bank
Deutsche Bank
CHF260.79→CHF300.48
Buy
―
Reiterated
11/07/25
Cencora price target raised to $371 from $322 at Deutsche BankCencora price target raised to $371 from $322 at Deutsche Bank
Mizuho Securities Analyst forecast on CH:ABG
Steven Valiquette
Mizuho Securities
Mizuho Securities
CHF275.37→CHF307.77
Buy
―
Reiterated
11/06/25
Cencora price target raised to $380 from $340 at MizuhoCencora price target raised to $380 from $340 at Mizuho
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on CH:ABG
Allen Lutz
Bank of America Securities
Bank of America Securities
CHF226.77→CHF230.82
Hold
―
Reiterated
06/24/26
Analysts Offer Insights on Healthcare Companies: Cencora (NYSE: COR), UnitedHealth (NYSE: UNH) and Humana (NYSE: HUM)
Barclays Analyst forecast on CH:ABG
Glen Santangelo
Barclays
Barclays
CHF344.21→CHF283.47
Buy
―
Reiterated
06/10/26
Barclays Reaffirms Their Buy Rating on Cencora (COR)
TD Cowen Analyst forecast on CH:ABG
Charles Rhyee
TD Cowen
TD Cowen
CHF323.96
Buy
―
Assigned
06/01/26
TD Cowen Reaffirms Their Buy Rating on Cencora (COR)
Wells Fargo Analyst forecast on CH:ABG
Stephen Baxter
Wells Fargo
Wells Fargo
CHF268.08
Buy
―
Reiterated
05/28/26
Cencora (COR) Receives a Buy from Wells Fargo
William Blair Analyst forecast on CH:ABG
Max Smock
William Blair
William Blair
―
Hold
―
Reiterated
05/22/26
Analysts Offer Insights on Healthcare Companies: Immuneering (NASDAQ: IMRX) and Cencora (NYSE: COR)
Morgan Stanley Analyst forecast on CH:ABG
Erin Wright
Morgan Stanley
Morgan Stanley
CHF323.96→CHF276.99
Buy
―
Reiterated
05/08/26
Cencora price target lowered to $342 from $400 at Morgan StanleyCencora price target lowered to $342 from $400 at Morgan Stanley
Robert W. Baird Analyst forecast on CH:ABG
Eric Coldwell
Robert W. Baird
Robert W. Baird
CHF340.16→CHF274.56
Buy
―
Reiterated
05/07/26
Cencora price target lowered to $339 from $420 at BairdCencora price target lowered to $339 from $420 at Baird
UBS Analyst forecast on CH:ABG
Kevin Caliendo
UBS
UBS
CHF332.06→CHF333.68
Buy
―
Reiterated
05/07/26
Cencora price target raised to $412 from $410 at UBSCencora price target raised to $412 from $410 at UBS
Citi Analyst forecast on CH:ABG
Daniel Grosslight
Citi
Citi
CHF328.01→CHF287.52
Buy
―
Reiterated
05/07/26
Cencora price target lowered to $355 from $405 at CitiCencora price target lowered to $355 from $405 at Citi
Evercore ISI Analyst forecast on CH:ABG
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
CHF291.57→CHF242.97
Buy
―
Reiterated
05/07/26
Cencora price target lowered to $300 from $360 at Evercore ISICencora price target lowered to $300 from $360 at Evercore ISI
Argus Research Analyst forecast on CH:ABG
David Toung
Argus Research
Argus Research
CHF323.96
Buy
―
Reiterated
03/17/26
Analysts Offer Insights on Healthcare Companies: Nuvation Bio (NYSE: NUVB) and Cencora (NYSE: COR)
J.P. Morgan Analyst forecast on CH:ABG
Lisa Gill
J.P. Morgan
J.P. Morgan
CHF337.73→CHF339.35
Buy
―
Reiterated
02/10/26
Cencora price target raised to $419 from $417 at JPMorganCencora price target raised to $419 from $417 at JPMorgan
Jefferies Analyst forecast on CH:ABG
Brian Tanquilut
Jefferies
Jefferies
CHF267.27→CHF356.36
Buy
―
Upgraded
01/22/26
Cencora upgraded to Buy from Hold at JefferiesCencora upgraded to Buy from Hold at Jefferies
Deutsche Bank Analyst forecast on CH:ABG
George Hill
Deutsche Bank
Deutsche Bank
CHF260.79→CHF300.48
Buy
―
Reiterated
11/07/25
Cencora price target raised to $371 from $322 at Deutsche BankCencora price target raised to $371 from $322 at Deutsche Bank
Mizuho Securities Analyst forecast on CH:ABG
Steven Valiquette
Mizuho Securities
Mizuho Securities
CHF275.37→CHF307.77
Buy
―
Reiterated
11/06/25
Cencora price target raised to $380 from $340 at MizuhoCencora price target raised to $380 from $340 at Mizuho
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cencora

3 Months
Charles RhyeeTD Cowen
Success Rate
27/39 ratings generated profit
69%
Average Return
+5.11%
Copying Charles Rhyee's trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +5.11% per trade.
1 Year
David ToungArgus Research
Success Rate
15/17 ratings generated profit
88%
Average Return
+18.34%
Copying David Toung's trades and holding each position for 1 Year would result in 88.24% of your transactions generating a profit, with an average return of +18.34% per trade.
2 Years
David ToungArgus Research
Success Rate
15/17 ratings generated profit
88%
Average Return
+34.74%
Copying David Toung's trades and holding each position for 2 Years would result in 88.24% of your transactions generating a profit, with an average return of +34.74% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ABG Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
5
6
Buy
13
13
12
17
15
Hold
3
3
2
6
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
16
16
14
28
27
In the current month, ABG has received 21 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. ABG average Analyst price target in the past 3 months is 280.23.
Each month's total comprises the sum of three months' worth of ratings.

ABG Financial Forecast

ABG Earnings Forecast

Next quarter’s earnings estimate for ABG is $3.48 with a range of $3.43 to $3.53. The previous quarter’s EPS was $3.80. ABG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ABG has Performed in-line its overall industry.
Next quarter’s earnings estimate for ABG is $3.48 with a range of $3.43 to $3.53. The previous quarter’s EPS was $3.80. ABG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ABG has Performed in-line its overall industry.

ABG Sales Forecast

Next quarter’s sales forecast for ABG is $67.43B with a range of $66.04B to $68.50B. The previous quarter’s sales results were $62.63B. ABG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ABG has Performed in-line its overall industry.
Next quarter’s sales forecast for ABG is $67.43B with a range of $66.04B to $68.50B. The previous quarter’s sales results were $62.63B. ABG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ABG has Performed in-line its overall industry.

ABG Stock Forecast FAQ

What is CH:ABG’s average 12-month price target, according to analysts?
Based on analyst ratings, Cencora, Inc.’s 12-month average price target is 280.23.
    What is CH:ABG’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:ABG, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Cencora, Inc. a Buy, Sell or Hold?
        Cencora, Inc. has a consensus rating of Strong Buy, which is based on 8 buy ratings, 2 hold ratings and 0 sell ratings.
          What is Cencora, Inc.’s share price target?
          The average share price target for Cencora, Inc. is 280.23. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $333.68 ,and the lowest forecast is $230.82. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Cencora, Inc.?
            Cencora, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
              How can I buy shares of Cencora, Inc.?
              To buy shares of CH:ABG, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.